HCKP1-11K
MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 1 - Immuno-Oncology Multiplex Assay
About This Item
推荐产品
种属反应性
human
制造商/商品名称
Milliplex®
技术
multiplexing: suitable
检测方法
fluorometric (Luminex® xMAP®)
储存温度
2-8°C
1 of 4
此商品 | HCKP211K | HCKP111KPX17 | HCKP111KPXBK17 |
---|---|---|---|
species reactivity human | species reactivity human | species reactivity human | species reactivity human |
manufacturer/tradename Milliplex® | manufacturer/tradename Milliplex® | manufacturer/tradename Milliplex® | manufacturer/tradename Milliplex® |
technique(s) multiplexing: suitable | technique(s) multiplexing: suitable | technique(s) multiplexing: suitable | technique(s) multiplexing: suitable |
detection method fluorometric (Luminex® xMAP®) | detection method fluorometric (Luminex® xMAP®) | detection method fluorometric (Luminex® xMAP®) | detection method fluorometric (Luminex® xMAP®) |
storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
一般描述
特异性
应用
特点和优势
包装
储存及稳定性
法律信息
免责声明
警示用语:
Danger
危险分类
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
靶器官
Respiratory Tract
储存分类代码
10 - Combustible liquids
法规信息
相关内容
评估免疫检查点有助于明确在PD-1/PD-L1免疫疗法中获益的患者,并为后续研究揭示新的免疫治疗靶点。了解如何使用MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 2进行免疫检查点分子的多重检测评估来研究NSCLC疗法。
Research evaluating immune checkpoints may help identify those likely to benefit from PD-1/PD-L1 immunotherapy and reveal new immunotherapy targets for future investigation. See how the MILLIPLEX® Human Immuno-Oncology Checkpoint Protein Panel 2 was used to multiplex immune checkpoint molecules for NSCLC research.
Cancer biomarker detection through MILLIPLEX® multiplex cancer assays can accelerate studies of tumorigenic processes helping advance cancer research.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持